Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDProtagenic Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.14 | $25,143 | |||
| 08/14/2024 | Q2 2024 | -$0.36 | $0 | |||
| 05/15/2024 | Q1 2024 | -$0.39 | $0 | |||
| 05/14/2024 | Q4 2023 | -$0.38 | $3,200 | |||
| 11/14/2023 | Q3 2023 | -$0.32 | $0 | |||
| 08/14/2023 | Q2 2023 | -$0.28 | $0 | |||
| 05/15/2023 | Q1 2023 | -$0.17 | $0 | |||
| 04/17/2023 | Q4 2022 | -$0.14 | $0 | |||
| 11/14/2022 | Q3 2022 | -$0.21 | $0 | |||
| 08/11/2022 | Q2 2022 | -$0.15 | $0 | |||
| 05/13/2022 | Q1 2022 | -$0.31 | $0 | |||
| 04/07/2022 | Q4 2021 | -$0.22 | $-480,510 | |||
| 11/15/2021 | Q3 2021 | -$0.21 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.43 | $0 | |||
| 05/17/2021 | Q1 2021 | -$0.46 | $0 | |||
| 03/25/2021 | Q4 2020 | -$0.20 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.41 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.22 | $0 | |||
| 06/18/2020 | Q1 2020 | -$0.19 | $0 | |||
| 04/28/2020 | Q4 2019 | -$0.29 | $0 |
Protagenic Therapeutics, Inc. Earnings: FAQ's
When is Protagenic Therapeutics, Inc.'s earnings date?
Protagenic Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
How can I listen to Protagenic Therapeutics, Inc.'s earnings conference
call?
The conference call for Protagenic Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Protagenic Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Protagenic Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Protagenic Therapeutics, Inc. generate each year?
Protagenic Therapeutics, Inc. (:PTIXW) has a recorded net income of $0. Protagenic Therapeutics, Inc. has generated $-1.15 earnings per share over the last four quarters.
What is Protagenic Therapeutics, Inc.'s price-to-earnings ratio?
Protagenic Therapeutics, Inc. (:PTIXW) has a price-to-earnings ratio of -0.38 and price/earnings-to-growth ratio is -0.03.